(EIDX) |
| 0 (0%) 10-11 03:14 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 132.54 |
| Resistance 1: | 126.31 |
| Pivot price: | 123.73 |
| Support 1: | 116.24 |
| Support 2: | 96.71 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 05 Oct 2020
BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement - GlobeNewswire
Wed, 10 Jun 2020
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Eidos Therapeutics, Inc. Buyout - GlobeNewswire
Mon, 12 Aug 2019
Little over year after IPO, biotech's majority owner wants to buy it all - The Business Journals
Thu, 27 Jun 2019
How Neil Kumar's new biotech model capped a $350 million IPO - The Business Journals
Mon, 12 Nov 2018
OPK To Report Data In Q1, EIDX Cheers Investors, Busy Year Ahead For VRCA - RTTNews
Fri, 22 Jun 2018
Eidos Therapeutics (EIDX) Stock Price, News & Analysis - MarketBeat
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
